Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	11.94B -45.8%
Revenue (ttm)	1.17B +30.7%
Net Income	142.15M +6.3%
EPS	0.66 -67.2%
Shares Out	66.76M
PE Ratio	271.06
Forward PE	39.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	113,910
Average Volume	391,193
Open	180.90
Previous Close	178.90
Day's Range	180.90 - 186.00
52-Week Range	165.00 - 346.40
Beta	0.43
RSI	42.55
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.